EquitAI LogoEquitAI
$86.34
-0.17%
ARWR

ARWR

Arrowhead Pharmaceuticals, Inc.

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
7/10
Quality
5/10
Growth
8/10
Strength
5/10
Dividend
1/10
Price Trend
Upwards
Momentum
Neutral
Balance Sheet
High Leverage
Earnings
Stable
Dividend Yield
0.00%
Market Cap
$12.20B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Arrowhead Pharmaceuticals develops medicines that treat stubborn diseases by silencing the genes that cause them. They use a proprietary platform to deliver these treatments directly to specific organs in the body. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...